Skip to main content
. Author manuscript; available in PMC: 2025 Mar 1.
Published in final edited form as: Drug Alcohol Depend. 2024 Feb 14;256:111125. doi: 10.1016/j.drugalcdep.2024.111125

Table 1.

Washington State Medicaid OUD population and MOUD average monthly utilization rates for three-month rolling averages.

OUD Population Hub and Spoke Non-Hub and Spoke
Pre-Period Post-Period Pre-Period Post-Period Pre-Period Post-Period
Model Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Rate* Monthly OUD Population 28030 1618 32982 1794 1243 147 2547 606 26787 1472 30435 1212
Any MOUD 39.73 1.72 50.49 3.77 39.71 2.42 60.27 9.12 39.73 1.70 49.59 3.25
Buprenorp hine 13.36 2.04 24.68 4.46 16.30 2.49 35.86 8.01 13.23 2.01 23.70 4.04
Methadone 25.90 0.89 24.60 1.29 22.38 0.70 21.54 1.45 26.06 0.91 24.82 1.41
Naltrexone 0.54 0.23 1.37 0.17 1.13 0.58 3.33 0.64 0.51 0.21 1.21 0.13

Notes.

*

=3 month rolling average MOUD Utilization SD= Standard Deviation. Pre-Period= January 01, 2016 – June 30, 2017, Post-Period= July 01, 2017 – June 30, 2019. Any MOUD includes buprenorphine, methadone, and naltrexone.